These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18020065)

  • 1. The effects of acidosis and hypothermia on blood transfusion requirements following factor VII administration.
    Hall K; Forrest P; Sawyer C
    Anaesth Intensive Care; 2007 Aug; 35(4):494-7. PubMed ID: 18020065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa in trauma patients with the 'triad of death'.
    Mitra B; Cameron PA; Parr MJ; Phillips L
    Injury; 2012 Sep; 43(9):1409-14. PubMed ID: 21345431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated coagulation factor VII and bleeding trauma patients.
    Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
    J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
    Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion.
    Perkins JG; Schreiber MA; Wade CE; Holcomb JB
    J Trauma; 2007 May; 62(5):1095-9; discussion 1099-101. PubMed ID: 17495707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII: a solution to refractory haemorrhage in vascular surgery?
    Warren OJ; Alcock EM; Choong AM; Leff DR; Van Herzeele I; Darzi AW; Athanasiou T; Cheshire NJ
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):145-52. PubMed ID: 17964194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of recombinant activated factor VII for blood loss after cardiovascular surgery].
    Gong ZY; Gao CQ; Xiao CS; Li BJ; Ma XH; Zhang CM
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1497-501. PubMed ID: 19094631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged effect of GlycoPEGylated rFVIIa (40k-PEG-rFVIIa) in rabbits correlates to activity in plasma.
    Johansen PB; Bjørn SE; Agersø H; Thorup I; Hermit MB; Sørensen B; Stennicke HR; Ezban M; Tranholm M
    Thromb Haemost; 2010 Jul; 104(1):157-64. PubMed ID: 20390231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
    Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
    Cochrane Database Syst Rev; 2012 Mar; (3):CD005011. PubMed ID: 22419303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Recombinant Factor VII as Rescue for Severe Perioperative Bleeding in HeartMate II Recipients.
    Karimi A; Daigle SS; Smith WB; Janelle GM; Klodell CT
    J Card Surg; 2015 Jun; 30(6):500-5. PubMed ID: 25939953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.
    Long MT; Wagner D; Maslach-Hubbard A; Pasko DA; Baldridge P; Annich GM
    Perfusion; 2014 Mar; 29(2):163-70. PubMed ID: 23942787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes.
    Masud F; Bostan F; Chi E; Pass SE; Samir H; Stuebing K; Liebl MG
    J Cardiothorac Vasc Anesth; 2009 Feb; 23(1):28-33. PubMed ID: 18948033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis.
    Tritapepe L; De Santis V; Vitale D; Nencini C; Pellegrini F; Landoni G; Toscano F; Miraldi F; Pietropaoli P
    Crit Care Med; 2007 Jul; 35(7):1685-90. PubMed ID: 17522585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
    Chapman AJ; Blount AL; Davis AT; Hooker RL
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rFVIIa in the trauma setting--practice patterns in United States trauma centers.
    Horton JD; DeZee KJ; Wagner M
    Am Surg; 2008 May; 74(5):413-7. PubMed ID: 18481498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.
    Lodge JP; Jonas S; Jones RM; Olausson M; Mir-Pallardo J; Soefelt S; Garcia-Valdecasas JC; McAlister V; Mirza DF;
    Liver Transpl; 2005 Aug; 11(8):973-9. PubMed ID: 16035095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes.
    MacLaren R; Weber LA; Brake H; Gardner MA; Tanzi M
    Transfusion; 2005 Sep; 45(9):1434-42. PubMed ID: 16131375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
    Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
    J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury.
    Yuan Q; Wu X; Du ZY; Sun YR; Yu J; Li ZQ; Wu XH; Mao Y; Zhou LF; Hu J
    J Crit Care; 2015 Feb; 30(1):116-20. PubMed ID: 25092615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
    Hacquard M; Durand M; Lecompte T; Boini S; Briançon S; Carteaux JP
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.